Rotavirus vaccination: successes and challenges
5:30pm - 7:00pm /
Tuesday 9th May 2017
/ Venue: Victoria Gallery & Museum
- 0151 794 2650
- Mathilde Chapal
- Admission: Free, please register here: https://www.liverpool.ac.uk/events/science-and-society/form/
- Book now
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
With Professor Nigel Cunliffe, Head of Department of Clinical Infection, Microbiology and Immunology, University of Liverpool
Rotavirus diarrhoea kills almost half a million infants and young children each year. Rotavirus vaccines are being introduced into childhood immunisation programmes to reduce this unacceptable burden of disease. While evidence of their early impact in the Americas and Europe is striking, their greatest value in reducing childhood deaths in Africa and Asia is yet to be fully realised. This lecture will review major achievements in the global battle against rotavirus and explore remaining challenges to successful disease control.
Professor Cunliffe is Professor of Medical Microbiology at the University of Liverpool and Honorary Consultant Microbiologist, Alder Hey Children’s NHS Foundation Trust.
He trained as a clinical microbiologist in Edinburgh and Liverpool and obtained a PhD from the University of Liverpool in 2001. His research interest is the epidemiology and prevention of diarrhoeal disease in children. Since the award in 1996 of a Wellcome Trust Research Training Fellowship in Clinical Tropical Medicine, Professor Cunliffe has led a long-term programme of rotavirus research in children in Malawi. This included a pivotal, Phase III clinical trial of human rotavirus vaccine which resulted in a global rotavirus vaccine recommendation by WHO.
Professor Cunliffe's work has been published in leading medical journals including the New England Journal of Medicine, the Lancet and Lancet Infectious Diseases.
Rotavirus diarrhoea kills almost half a million infants and young children each year. Rotavirus vaccines are being introduced into childhood immunisation programmes to reduce this unacceptable burden of disease. While evidence of their early impact in the Americas and Europe is striking, their greatest value in reducing childhood deaths in Africa and Asia is yet to be fully realised. This lecture will review major achievements in the global battle against rotavirus and explore remaining challenges to successful disease control.
Professor Cunliffe is Professor of Medical Microbiology at the University of Liverpool and Honorary Consultant Microbiologist, Alder Hey Children’s NHS Foundation Trust.
He trained as a clinical microbiologist in Edinburgh and Liverpool and obtained a PhD from the University of Liverpool in 2001. His research interest is the epidemiology and prevention of diarrhoeal disease in children. Since the award in 1996 of a Wellcome Trust Research Training Fellowship in Clinical Tropical Medicine, Professor Cunliffe has led a long-term programme of rotavirus research in children in Malawi. This included a pivotal, Phase III clinical trial of human rotavirus vaccine which resulted in a global rotavirus vaccine recommendation by WHO.
Professor Cunliffe's work has been published in leading medical journals including the New England Journal of Medicine, the Lancet and Lancet Infectious Diseases.